Incidence and Risk Factors of Early Onset Colorectal Cancer

Sponsor
Hospital Frydek-Mistek (Other)
Overall Status
Completed
CT.gov ID
NCT05184751
Collaborator
(none)
18,257
119

Study Details

Study Description

Brief Summary

Early onset colorectal cancer (cancer in person younger than 50 years) has increasing incidence last years. The aim of our study was to assess the real-life incidence of early onset colorectal cancer, advanced neoplasias (colorectal cancer and/or advanced adenoma) and all neoplastic lesions in total in a single non-university endoscopic center.

Condition or Disease Intervention/Treatment Phase
  • Other: colonoscopy

Detailed Description

The investigators retrospectively assessed the incidence of all neoplastic lesions, advanced neoplasias and colorectal cancer in population under 50 years of age compared to population 50 years and older. The investigators collected the data from all colonoscopic examinations performed in non-university hospital Frydek-Mistek from January 2012 to the end of June 2021.

Study Design

Study Type:
Observational
Actual Enrollment :
18257 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Incidence and Risk Factors of Early Onset Colorectal Cancer
Actual Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Jun 30, 2021
Actual Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
50 years and over

patients who underwent colonoscopic examination aged 50 years and over

Other: colonoscopy

under 50 years

patients who underwent colonoscopic examination aged under 50 years

Other: colonoscopy

Outcome Measures

Primary Outcome Measures

  1. incidence of early onset colorectal neoplasias, risk factors [10 years]

    the real-life incidence of early onset colorectal cancer, advanced neoplasias (colorectal cancer and/or advanced adenoma) and all neoplastic lesions in total in a single non-university endoscopic center, the risk of sex and family history of colorectal cancer

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 97 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: all patient who underwent colonoscopic examination clear indication for colonoscopy

Exclusion Criteria: not able to underwent colonoscopy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hospital Frydek-Mistek

Investigators

  • Principal Investigator: Ivana Mikoviny Kajzrlikova, Hospital Frydek-Mistek

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ivana Mikoviny Kajzrlikova, MD, PhD, MD, PhD, Head of endoscopic department, Hospital Frydek-Mistek
ClinicalTrials.gov Identifier:
NCT05184751
Other Study ID Numbers:
  • Early onset colorectal cancer
First Posted:
Jan 11, 2022
Last Update Posted:
Jan 31, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 31, 2022